Clinical Trials Browser

Phase 2 × ispinesib × Genitourinary × Clear all

NCT00354250 2013-06-05

Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer

Phase 2 Completed

Carcinoma, Renal Cell

NCT00096499 2013-01-25

SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel

Phase 2 Completed

Prostatic Neoplasms